DMRA vs KARD: stock comparison and AI forecast
Damora Therapeutics, Inc. (DMRA) and Kardigan, Inc. (KARD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DMRA Damora Therapeutics, Inc.
- Market Cap
- $1.33B
- P/E Ratio
- 2.7x
- Size
- small-cap
- AI Forecast
KARD Kardigan, Inc.
- Price
- $14.21 -35.6% · 6M
- Market Cap
- $1.33B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DMRA and KARD have similar market capitalizations ($1.33B and $1.33B).
- KARD carries 0.17 times debt per unit of equity, against 0.05 times for DMRA.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DMRA | KARD |
|---|---|---|
| Market Cap | $1.33B | $1.33B |
| P/E Ratio | 2.66x | – |
| P/B Ratio | 2.58x | 2.16x |
| EPS | $8.11 | – |
| Book Value/Share | $8.36 | $6.58 |
Profitability & Margins
| Metric | DMRA | KARD |
|---|---|---|
| ROIC | -52.4% | – |
| Tax Rate | -0.1% | – |
Financial Health
| Metric | DMRA | KARD |
|---|---|---|
| Current Ratio | 19.73x | 8.72x |
| D/E Ratio | 0.05x | 0.17x |
| Financial Leverage | 1.05x | 1.17x |
| Interest Coverage | -8.6x | – |
| Working Capital | $516M | $540M |
Cash Flow
| Metric | DMRA | KARD |
|---|---|---|
| Operating Cash Flow | -$45M | – |
Income Statement
| Metric | DMRA | KARD |
|---|---|---|
| Operating Income | -$271M | – |
| R&D Expense | $74M | – |
Dividend & Shareholder Information
| Metric | DMRA | KARD |
|---|---|---|
| Shares Outstanding | 62M | 94M |
DMRA vs KARD: stock comparison and AI forecast
Which is bigger, DMRA or KARD?
DMRA and KARD have similar market capitalizations ($1.33B and $1.33B).
Which one does Intratio's AI model rank higher, DMRA or KARD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.